Invitrogen™ Human IL-13 R alpha 1/IL-13 R1 ELISA Kit

Ref.: BL-RE-106927Manufacturer ref.: EH257RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human IL-13 R alpha 1/IL-13 R1 quantitates human IL-13 R alpha 1/IL-13 R1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IL-13 R alpha 1/IL-13 R1.

Accession number
Ai882074 ; antigène Cancer/testis 19 ; antigène CD CD213a1 ; antigène CD213a1 ; antigène CD213a1 ; CT19 ; chaîne du récepteur IL13 alpha-1 ; sous-unité du récepteur IL-13 alpha-1 ; IL13R ; sous-unité IL-13 R alpha-1 ; IL-13 r[a] ; IL13RA ; IL-13 Ra ; Il13ra1 ; Il-13 RA1 ; IL-13 R-alpha-1 ; sous-unité alpha 1 du récepteur de l’interleukine 13 ; récepteur de l’interleukine 13, alpha 1 ; récepteur de l’interleukine 13, similaire à l’alpha 1 ; Sous-unité alpha-1 du récepteur de l’interleukine-13 ; protéine liant l’interleukine-13 ; COL100360218 ; récepteur de cytokine Novel 4 ; NR4
Dose range
0.05 to 10 ng/mL
Sensitivity of the dosage
0.05 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human IL-13 R alpha 1/IL-13 R1 quantitates human IL-13 R alpha 1/IL-13 R1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IL-13 R alpha 1/IL-13 R1.

Human IL-13 R alpha 1/IL-13 R1 quantitates human IL-13 R alpha 1/IL-13 R1 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human IL-13 R alpha 1/IL-13 R1.

The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with the IL4 alpha receptor, a subunit shared by the IL13 and IL4 receptors. This subunit serves as the primary IL13 binding subunit of the IL13 receptor and can also be a component of the IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2 and can therefore mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4.

Sensitivity

Sensitivity of dosage: 0.05 ng/mL.

Measurement range

Dose range: 0.05-10 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: IL13RA1.

Samples

Type of sample: Plasma, Serum, Surnatant (surnatant volume, 50 µl; plasma, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17155019
Specifications
Accession numberAi882074; Cancer/testis antigen 19; CD CD213a1 antigen; CD213a1 antigen; CD213a1 antigen CT19; IL13 alpha-1 receiver chain; IL-13 alpha-1 receiver subunit; IL13R; subunit IL-13 R alpha-1; IL-13 r[a]; IL13RA; IL-13 Ra; Il13ra1; Il-13 RA1; IL-13 R-alpha-1; subunit
Dose range0.05 to 10 ng/mL
Sensitivity of the dosage0.05 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)P78552
Gene symbol(s)IL13RA1
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetIL13RA1
Test time1 h 20 min
Physical characteristics
Volume of sampleSupernatant, 50 µl; plasma, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH257RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.